Basics Black Diamond Therapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $152.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.69% Avg Daily Range (30 D): $0.14 | 3.53% Avg Daily Range (90 D): $0.12 | 3.47% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): 1.32M Avg Daily Volume (90 D): 1.05M Trade Size Avg Trade Size (Sh.): 134 Avg Trade Size (Sh.) (30 D): 146 Avg Trade Size (Sh.) (90 D): 155 Institutional Trades Total Inst.Trades: 372 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.73M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $.78M Avg Closing Trade (90 D): $.78M Avg Closing Volume: 173.01K     News Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $.38 $-.15 $-.19 Diluted EPS $.37 $-.15 $-.19 Revenue $ 70M $ M $ M Gross Profit $ $ $ Net Income / Loss $ 21.5M $ -8.5M $ -10.56M Operating Income / Loss $ 11.86M $ -10.98M $ -13.42M Cost of Revenue $ $ $ Net Cash Flow $ 7.44M $ .87M $ -68.43M PE Ratio 7.32